Video

Clyde Markowitz From University of Pennsylvania: Moving Multiple Sclerosis Treatment Forward for All

Author(s):

It was not that long ago when doctors would sometimes not discuss the diagnosis of multiple sclerosis with their patients. Now not only is it a condition they can diagnose but treatment is also progressing by leaps and bounds.

It was not that long ago when doctors would sometimes not discuss the diagnosis of multiple sclerosis with their patients. Now not only is it a condition they can diagnose but treatment is also progressing by leaps and bounds.

Clyde E. Markowitz, MD, from the University of Pennsylvania discussed a recent course given to new members of the field ahead of the annual meeting of the Consortium of Multiple Sclerosis Care Centers during a recent interview with MD Magazine. Markowitz said doctors entering the field now are considerably further ahead in their treatment options for patients than those that came before them and should see even more development in the field before their time is done.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.